ClinicalTrials.Veeva

Menu

IRIS-PREMIER REGISTRY

S

Seung-Jung Park

Status

Completed

Conditions

Coronary Artery Disease
Myocardial Ischemia
Heart Diseases
Coronary Disease

Treatments

Device: Promus PREMIER

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02060968
AMCCV2014-03

Details and patient eligibility

About

The purpose of this study is to evaluate effectiveness and safety of Promus PREMIER in Routine Clinical Practice

Enrollment

2,006 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 20 and more
  • Intervention with Promus PREMIER everolimus eluting coronary stent
  • Agreed with written informed consent form

Exclusion criteria

  • Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
  • Life expectancy of 1year and under
  • Cardiac shock

Trial design

2,006 participants in 1 patient group

IRIS PREMIER Cohort
Description:
Promus PREMIER
Treatment:
Device: Promus PREMIER

Trial contacts and locations

25

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems